This chapter reviews the new direct oral anticoagulants - thrombin and Xa inhibitors. The specific drugs are reviewed as well as the specific indications - prevention and treatment of deep venous thrombosis, stroke prevention in atrial fibrillation, and acute coronary syndrome. Finally, common issues such as monitoring and choosing the appropriate patient to use the drugs in are reviewed.
|Original language||English (US)|
|Title of host publication||Hemostasis and Thrombosis|
|Subtitle of host publication||Fourth Edition|
|Publisher||Springer International Publishing|
|Number of pages||5|
|State||Published - Jan 1 2019|
ASJC Scopus subject areas